YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Sintx Technologies, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Pivot from Development to Commercial Platform Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you…
Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Brinker International (EAT [https:…
Globus Medical (GMED) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.86 per share a year ago. These figures are adjusted for non-recurring items…
LivaNova (LIVN) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non-recurring items. This…
* SINTX Technologies (SINT [https://seekingalpha.com/symbol/SINT]) said [https://seekingalpha.com/pr/20538874-sintx-technologies-announces-raise-of-approximately-5_0-million-of-capital-including-a-4_5]on Wednesday it had agreed to issue an…
Waters (WAT) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.25 per share a year ago. These figures are adjusted for non-recurring items. This qua…
The European stock market has recently experienced a notable upswing, with the pan-European STOXX Europe 600 Index rising by 3.05% amid improved investor sentiment following geopolitical developments. Despite this positive momentum, econom…
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX…
SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announce…
NEW YORK, NY / ACCESS Newswire / December 9, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day Year-End Virtual Investor Conference taking place Wednesday…
ציון דרך שמאפשר ייצור מיידי של התקני SiN/PEEK בהתאמה אישית סולט לייק סיטי, יוטה, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc.(נאסד"ק: SINT) ("SINTX" או "החברה"), חברה לייצור קרמיקה וחומרים ביולוגיים מתקדמים, הודיעה כי חתמה על…
เมืองซอลต์เลกซิตี รัฐยูทาห์ วันที่ , Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” หรือ “บริษัท”) ซึ่งเป็นบริษัทด้านเซรามิกส์และวัสดุชีวภาพขั้นสูง ได้ประกาศในวันนี้ว่า บริษัทได้ลงนามในข้อตกลงจัดหาวัสดุก…
El hito permite la producción inmediata de dispositivos personalizados de SiN/PEEK SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” o la “Compañía”), una empresa de cerámicas avanzada…
Contrato viabiliza a produção imediata de dispositivos personalizados SiN/PEEK SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- A SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” ou a “Empresa”), uma empresa de cerâmica e biomateria…
SALT LAKE CITY, Utah, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” atau “Syarikat”), sebuah syarikat seramik dan biobahan termaju, hari ini mengumumkan bahawa ia telah menandatangani perjanjian bekalan…
SiN/PEEK 맞춤 장비 생산에 즉시 착수할 수 있게 돼 미국 유타주 솔트레이크시티, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 첨단 세라믹과 생체소재 회사인 SINTX Technologies, Inc.(나스닥명: SINT) (이하 “SINTX” 또는 “회사”)가 특허를 획득한 실리콘 나이트라이드-PEEK 복합소재(SiN/PEEK) (미국 특허 제10,806,831호)를 제조하기 위해 고성능 폴리머 분야의…
ユタ州ソルトレイクシティ発 , Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進セラミックスおよびバイオマテリアル企業であるシンテックス・テクノロジーズ (SINTX Technologies, Inc.)(NASDAQ: SINT)(以下「SINTX」または「同社」) は本日、高性能ポリマー分野の世界的リーダーであるエボニック (以下「エボニック」)と供給契約を締結したことを発表した。シンテックスの米国生産施設に既に設置されている設備を用いて生産さ…
SALT LAKE CITY, Utah, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” atau “Perusahaan”), perusahaan keramik dan biomaterial canggih, hari ini mengumumkan bahwa pihaknya telah menandatangani perjanjian pa…
SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) („SINTX” oder das „Unternehmen”), ein Unternehmen für innovative Keramik und Biomaterialien, gab heute die Unterzeichnung eines Liefervertrags…
SALT LAKE CITY, Utah, 01 déc. 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ : SINT) (« SINTX » ou « la Société »), une entreprise spécialisée dans les céramiques avancées et les biomatériaux, a annoncé aujourdʼhui avoir signé u…
猶他州鹽湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進陶瓷與生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) (「SINTX」或「該公司」) 今日宣佈，已與高性能聚合物全球領導者 Evonik Corporation (「EVONIK」) 簽署供應協議，生產該公司專利的氮化矽–PEEK（即聚醚醚酮）複合材料 (SiN/PEEK) (美國專利編號：10,806,831)，此材料專為人工智能 (AI)…
犹他州盐湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先进陶瓷和生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) （简称“SINTX”或“公司”）今天宣布，已与高性能聚合物领域的全球领导企业 Evonik Corporation（简称“EVONIK”）签署供应协议，由 EVONIK 生产 SINTX 的专有氮化硅-PEEK 复合材料（SiN/PEEK，美国专利号 10806831）。该材料专为人工智能…
Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company, to…
* Sintx Technologies press release [https://seekingalpha.com/pr/20306037-sintx-reports-pivotal-third-quarter-business-update-and-financial-highlights-driven-by-fda] (SINT [https://seekingalpha.com/symbol/SINT]): Q3 GAAP EPS of -$3.46 misse…
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures are adjusted for non-recurring items. A qua…
Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in adva…
* Sintx Technologies (NASDAQ:SINT [https://seekingalpha.com/symbol/SINT]) filed to sell 1.74M shares of common stock for holders. * This prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10555452] MORE ON SINTX…
Integer (ITGR) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.43 per share a year ago. These figures are adjusted for non-recurring items. This…
FDA認可を受け、米国内で製造された本インプラントシステムにより、シントクスは数十億ドル規模の米国市場への参入を実現 ユタ州ソルトレイクシティ発, Oct. 21, 2025 (GLOBE NEWSWIRE) -- シリコンナイトライド (Si₃N₄) のバイオメディカル用途に特化した先進セラミック分野のリーダーであるシントクス・テクノロジーズ (SINTX Technologies, Inc.) (NASDAQ: SINT) (「シントクス」または「同社」) は本日、SI…
Sistem implan yang disetujui FDA dan diproduksi di AS menempatkan SINTX untuk memasuki pasar AS senilai miliaran dolar SALT LAKE CITY, Utah, Oct. 21, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” atau “Perusahaa…
ה-FDA אישר ומערכת שתלים מתוצרת ארה"ב- ממצבת את SINTX בכניסה לשוק האמריקני של מיליארד דולר סולט לייק סיטי, יוטה, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc.(נאסד"ק: SINT) ("SINTX" או "החברה"), חדשנית קרמיקה מתקדמת המתמחה בייש…
Das von der FDA zugelassene und in den USA hergestellte Implantatsystem positioniert SINTX für den Eintritt in den milliardenschweren US-Markt SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT)…
Fabriqué aux États-Unis et désormais approuvé par la FDA, ce système d’implant conçu par SINTX s’ouvre les portes d’un marché américain valorisé à plusieurs milliards de dollars SALT LAKE CITY, Utah, 20 oct. 2025 (GLOBE NEWSWIRE) -- SINTX…
獲 FDA 批准並在美國製造的植入系統推動 SINTX 進軍價值數十億美元的美國市場 猶他州鹽湖城, Oct. 21, 2025 (GLOBE NEWSWIRE) -- 專注於氮化矽 (Si₃N₄) 生物醫學應用的先進陶瓷創新公司 SINTX Technologies, Inc. (NASDAQ: SINT) (「SINTX」或「公司」) 今天宣佈 SINAPTIC® Foot & Ankle Osteotomy Wedge System（足踝截骨楔形系統）獲得 U.S.…
新たな米国特許が競争優位性を強化し、主要市場におけるライセンス供与および製品機会の拡大を可能に ユタ州ソルトレイクシティ発, Oct. 17, 2025 (GLOBE NEWSWIRE) -- シリコンナイトライド (Si₃N₄) のバイオメディカル用途に特化した先進セラミックの革新企業であるシントクス・テクノロジーズ (SINTX Technologies, Inc.) (NASDAQ: SINT) (「シントクス」または「同社」) は本日、米国特許商標庁 (USPTO)…
Paten baharu di Amerika Syarikat mengukuhkan kelebihan daya saing dan membuka peluang pelesenan serta pengkomersialan produk yang lebih meluas merentasi pasaran utama SALT LAKE CITY, Utah, Oct. 17, 2025 (GLOBE NEWSWIRE) -- SINTX Technologi…